Showing results (81-90 of 189) with videos related to
Sort By:
Pageof 19
Cancer Journal (Sudbury, Mass.)|August 3, 2004
The impact of prostate volume and neoadjuvant androgen-deprivation therapy on urinary function following prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.American Journal of Clinical Oncology|December 3, 2011
The impact of diabetes mellitus on survival in men with clinically localized prostate cancer treated with permanent interstitial brachytherapyMadhu B Shetti, Gregory S Merrick, Wayne M Butler, et al.International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Electromagnetic transponders indicate prostate size increase followed by decrease during the course of external beam radiation therapyBenjamin L King, Wayne M Butler, Gregory S Merrick, et al.Urology|March 18, 2008
Role of trospium chloride in brachytherapy-related detrusor overactivityNathan Bittner, Gregory S Merrick, Sarah Brammer, et al.Radiation Oncology (London, England)|July 24, 2009
cExternal beam radiation results in minimal changes in post void residual urine volumes during the treatment of clinically localized prostate cancerPeter F Orio, Gregory S Merrick, Zachariah A Allen, et al.BJU International|March 8, 2008
The morbidity of transperineal template-guided prostate mapping biopsyGregory S Merrick, Walter Taubenslag, Hugo Andreini, et al.International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
Serum testosterone kinetics after brachytherapy for clinically localized prostate cancerAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.Brachytherapy|March 13, 2012
Prognostic importance of tobacco use in men receiving definitive prostate brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.International Journal of Radiation Oncology, Biology, Physics|May 2, 2008
Primary causes of death after permanent prostate brachytherapyNathan Bittner, Gregory S Merrick, Robert W Galbreath, et al.International Journal of Radiation Oncology, Biology, Physics|January 2, 2009
Pretreatment serum testosterone and androgen deprivation: effect on disease recurrence and overall survival in prostate cancer patients treated with brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.Pageof 19